These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1085502)

  • 1. Induction of cytotoxic lymphocytes directed against public alloantigens.
    Leben ML; Morris LM; Boyle W
    Tissue Antigens; 1976 Jul; 8(1):1-7. PubMed ID: 1085502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The major histocompatibility complex determines susceptibility to cytotoxic T cells directed against minor histocompatibility antigens.
    Bevan MJ
    J Exp Med; 1975 Dec; 142(6):1349-64. PubMed ID: 53263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-mediated immune responses in vitro. II. Simultaneous generation of cytotoxic lymphocyte responses to two sets of alloantigens of limited cross-reactivity.
    Peavy DL; Pierce CW
    J Immunol; 1975 Dec; 115(6):1515-20. PubMed ID: 1184965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Separate clones of cytotoxic T lymphocytes are generated against private and public H-2 antigens.
    Schnagl HY; Boyle W
    Transplantation; 1980 Jun; 29(6):492-7. PubMed ID: 6967640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative studies on the precursors of cytotoxic lymphocytes. II. Specificity of precursors responsive to alloantigens and to concanavalin A.
    Teh HS; Phillips RA; Miller RG
    J Immunol; 1977 Mar; 118(3):1057-62. PubMed ID: 66268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. H-2 I alloantigens and recall of memory cytotoxic responses.
    Orosz CG; Macphail S; Bach FH
    J Supramol Struct; 1980; 14(1):121-7. PubMed ID: 6971370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of tumor-specific transplantation antigens to the histocompatibility complex: dissociation of in vitro alloantigen expression and in vivo alloimmunity from tumor-specific transplantation antigen strength.
    Chauvenet PH; Smith RT
    Int J Cancer; 1978 Jul; 22(1):79-90. PubMed ID: 79560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alloantigen pretreatment induces a down-regulation of the in vivo subsequent development of cytotoxic T lymphocytes directed against linked alloantigens.
    Schutze MP; Langlade-Demoyen P; Przewlocki G; Leclerc C
    Eur J Immunol; 1989 Aug; 19(8):1365-71. PubMed ID: 2789138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of mixed lymphocyte cultures and cytotoxic responses: evidence that T cells express SD but not LD antigens, whereas B cells express both.
    Simpson E
    Eur J Immunol; 1976 Jul; 5(7):456-61. PubMed ID: 135688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exclusive involvement of H-2Db or H-2Kd product in the interaction between T-killer lymphocytes and syngeneic H-2b or H-2d viral lymphomas.
    Gomard E; Duprez V; Reme T; Colombani MJ; Levy JP
    J Exp Med; 1977 Oct; 146(4):909-22. PubMed ID: 197198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The secondary cytotoxic response to allogeneic cells: the specificity of secondary cytotoxic effectors differs from that of primary effectors.
    Taniguchi K; Nomoto K; Kubo C; Nanishi F
    Jpn J Exp Med; 1981 Apr; 51(2):89-95. PubMed ID: 6974264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-mediated lympholysis of trinitrophenyl-modified autologous lymphocytes. Effector cell specificity to modified cell surface components controlled by H-2K and H-2D serological regions of the murine major histocompatibility complex.
    Shearer GM; Rehn TG; Garbarino CA
    J Exp Med; 1975 Jun; 141(6):1348-64. PubMed ID: 47900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alloantigen-activated lysis of syngenic tumor augmented by allogenic lymphocytes as cold targets.
    Sugarbaker PH; Matthews W
    Oncology; 1985; 42(6):377-83. PubMed ID: 2933618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of cytotoxic lymphocyte responses in vitro by alloantigen-activated spleen cells.
    Truitt GA; Rich RR; Rich SS
    J Immunol; 1977 Jul; 119(1):31-7. PubMed ID: 874322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minor H antigens introduced on H-2 different stimulating cells cross-react at the cytotoxic T cell level during in vivo priming.
    Bevan MJ
    J Immunol; 1976 Dec; 117(6):2233-8. PubMed ID: 825578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative studies on the precursors of cytotoxic lymphocytes. IV. Specificity and cross-reactivity of cytotoxic clones.
    Teh HS; Phillips RA; Miller RG
    J Immunol; 1978 Feb; 120(2):425-8. PubMed ID: 74388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H-2 effects on cell-cell interactions in the response to single non-H-2 alloantigens. II. H-2D region control of H-7.1-specific stimulator function in mixed lymphocyte culture and susceptibility to lysis by H-7.1-specific cytotoxic cells.
    Wettstein PJ; Frelinger JA
    J Exp Med; 1977 Nov; 146(5):1356-66. PubMed ID: 144769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the induction and expression of T cell-mediated immunity. IV. Non-overlapping populations of alloimmune cytotoxic lymphocytes with specificity for tumor-associated antigens and transplantation antigens.
    Kedar E; Bonavida B
    J Immunol; 1975 Nov; 115(5):1301-8. PubMed ID: 51889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. H-2-linked genetic control of murine T-cell-mediated lympholysis to autologous cells modified with low concentrations of trinitrobenzene sulfonate.
    Shearer GM; Schmitt-Verhulst AM; Pettinelli CB; Miller MW; Gilheany PE
    J Exp Med; 1979 Jun; 149(6):1407-23. PubMed ID: 109569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of cytotoxic T lymphocytes against Ly alloantigen.
    Röllinghoff M; Pfizenmaier K; Starzinski-Powitz AS; Wagner H
    Scand J Immunol; 1977; 6(11):1121-5. PubMed ID: 304243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.